DE3587503T2 - Antigene aus plasmodium-falciparum. - Google Patents

Antigene aus plasmodium-falciparum.

Info

Publication number
DE3587503T2
DE3587503T2 DE85904583T DE3587503T DE3587503T2 DE 3587503 T2 DE3587503 T2 DE 3587503T2 DE 85904583 T DE85904583 T DE 85904583T DE 3587503 T DE3587503 T DE 3587503T DE 3587503 T2 DE3587503 T2 DE 3587503T2
Authority
DE
Germany
Prior art keywords
falciparum
plasmodium
antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE85904583T
Other languages
English (en)
Other versions
DE3587503D1 (en
Inventor
David James Kemp
Robin Fredric Anders
Ross Leon Coppel
Graham Vallancey Brown
Robert Bryce Saint
Alan Frederick Cowman
Albert Edward Bianco
Graham Frank Mitchell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Saramane Pty Ltd
Original Assignee
Saramane Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Saramane Pty Ltd filed Critical Saramane Pty Ltd
Publication of DE3587503D1 publication Critical patent/DE3587503D1/de
Application granted granted Critical
Publication of DE3587503T2 publication Critical patent/DE3587503T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE85904583T 1984-09-11 1985-09-10 Antigene aus plasmodium-falciparum. Expired - Fee Related DE3587503T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPG706684 1984-09-11
AUPG706784 1984-09-11

Publications (2)

Publication Number Publication Date
DE3587503D1 DE3587503D1 (en) 1993-09-09
DE3587503T2 true DE3587503T2 (de) 1993-11-25

Family

ID=25642846

Family Applications (1)

Application Number Title Priority Date Filing Date
DE85904583T Expired - Fee Related DE3587503T2 (de) 1984-09-11 1985-09-10 Antigene aus plasmodium-falciparum.

Country Status (13)

Country Link
EP (1) EP0193586B1 (de)
JP (1) JPH0698773A (de)
AU (1) AU599305B2 (de)
CA (1) CA1340213C (de)
DE (1) DE3587503T2 (de)
GB (1) GB2176191B (de)
HK (1) HK132693A (de)
IL (1) IL76338A (de)
MY (1) MY102593A (de)
OA (1) OA08325A (de)
SG (2) SG65089G (de)
WO (1) WO1986001802A1 (de)
ZW (1) ZW14985A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU584881B2 (en) * 1984-02-21 1989-06-08 British Technology Group Limited Improvements in or relating to the production of malaria vaccines
IL81026A0 (en) * 1985-12-24 1987-03-31 Inst Medical W & E Hall Peptides for immunizing against plasmodium falciparum,dna molecules coding for them and compositions containing said peptides
AU606042B2 (en) * 1985-12-24 1991-01-31 Saramane Pty Ltd Asexual blood stage antigens of plasmodium falciparum
IL81890A0 (en) * 1986-03-14 1987-10-20 Saramane Pty Ltd Polypeptides providing protective immunity against malaria
US5006514A (en) * 1986-03-20 1991-04-09 Sawai Pharmaceutical Co., Ltd. α,α-trehalose trimycolates and pharmaceutical compositions
IT1213576B (it) * 1986-12-23 1989-12-20 Eniricerche Spa Composizione polipeptidica utile per la preparazione di vaccini antimalaria e di kits diagnostici per la determinazione di anticorpi antimerozoite.
FR2672290B1 (fr) 1991-02-05 1995-04-21 Pasteur Institut Sequences peptidiques specifiques des stades hepatiques de p. falciparum porteuses d'epitopes capables de stimuler les lymphocytes t.
US5532133A (en) * 1993-06-02 1996-07-02 New York University Plasmodium vivax blood stage antigens, PvESP-1, antibodies, and diagnostic assays

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU569722B2 (en) * 1983-01-28 1988-02-18 Saramane Pty Ltd Expression of plasmodium falciparum polypeptides from cloned cdna
GB8404378D0 (en) * 1984-02-20 1984-03-28 Biogen Nv Dna sequence recombinant dna molecules
IL74409A (en) * 1984-02-22 1994-08-26 Wellcome Found Cloning of the p195 gene of p. falciparum and fragments thereof
WO1986004922A1 (en) * 1985-02-20 1986-08-28 Memorial Sloan-Kettering Cancer Center cDNA CODING FOR PLASMODIUM FALCIPARUM GLYCOPHORIN BINDING PROTEINS WEIGHING 130,000 DALTONS AND 155,000 DALTONS

Also Published As

Publication number Publication date
SG119293G (en) 1994-01-21
JPH0698773A (ja) 1994-04-12
GB2176191A (en) 1986-12-17
OA08325A (en) 1988-02-29
WO1986001802A1 (en) 1986-03-27
MY102593A (en) 1992-08-17
ZW14985A1 (en) 1986-01-29
EP0193586A1 (de) 1986-09-10
SG65089G (en) 1990-01-26
DE3587503D1 (en) 1993-09-09
EP0193586B1 (de) 1993-08-04
HK132693A (en) 1993-12-10
AU4732685A (en) 1986-03-20
GB8610243D0 (en) 1986-05-29
CA1340213C (en) 1998-12-15
IL76338A (en) 1994-08-26
GB2176191B (en) 1989-06-01
EP0193586A4 (de) 1988-03-22
AU599305B2 (en) 1990-07-19

Similar Documents

Publication Publication Date Title
DE3578966D1 (de) Verbindungsmechanismus.
DE3382572D1 (de) Antikoerper-verbindungen.
NO880395D0 (no) Antigener.
IT1212114B (it) Molla.
ATE41922T1 (de) Alkylsulfonamidophenylalkylamine.
IT8419343A0 (it) Antigene di peptide protettivo.
FI854301A0 (fi) Solubiliserad platinafoerening.
DE3580413D1 (de) Gasfeder.
DE3574536D1 (de) Schablonengewickelte spule.
DE3583341D1 (de) Leberwurm-antigene.
FI850150A0 (fi) Form foer en likriktad seismisk spaorparameter.
DE3577510D1 (de) Reissverschluss.
DE3587503T2 (de) Antigene aus plasmodium-falciparum.
DE3585887D1 (de) Reissverschluss.
IT1206479B (it) Lega di tantalio - columbio molibdeno - tungsteno.
FI851328A0 (fi) Doerr avsedd foer t-formig oeppning.
DE3577310D1 (de) 1,6-hexandiamide aus 3-pentenamiden.
NO850375L (no) Gassabsorpsjonssystem.
IT8520399A0 (it) Chiodatrice elettromagnetica.
ATE76755T1 (de) Verbesserte antigenzusammensetzung.
IT1213146B (it) Bobina bicentrica.
FI904226A0 (fi) Foer hb-alc specifika monoklonala antikroppar.
IT8430667V0 (it) Struttura di bobina.
FI843033A0 (fi) Propp.
ATE36229T1 (de) Federgefuege.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee